Jump to section · 9 parts
Part 1
The cap is new. The penalty is permanent.
Two facts about Medicare drug coverage are worth holding at the same time, because they pull in opposite directions.
The first is genuinely good news and it is recent. Under current law there is now a ceiling on what counts as a person's costs for covered drugs in a year. Above it, cost sharing stops entirely. For decades there was no such limit, and a serious diagnosis meant an open-ended bill.
The second is that not taking drug coverage when first eligible carries a penalty that is added to the premium for as long as the person has coverage. Not for a year. For the rest of their life, and rising as premiums rise.
Those two together define the shape of the decision. The protection only exists inside a plan, and the cost of standing outside one compounds quietly for as long as you stand there.
These are federal rules and they apply the same way in every state, although the plans themselves are sold by private companies and what any particular plan covers varies.
This guide is educational information. It is not legal, tax or financial advice.
Part 2
What a year now looks like
A standard drug plan year in 2026 runs through phases, and the enrollee pays a different share in each.
| Phase | What the enrollee pays | Until |
|---|---|---|
| Deductible | All of it | $615 has been paid in 2026 |
| Initial coverage | 25 percent of the cost | Out-of-pocket spending reaches $2,100 |
| Catastrophic | Nothing | The end of the year |
That third row is the change. Once a person's out-of-pocket spending on covered drugs reaches the annual threshold, there is no further cost sharing for covered drugs for the rest of that year.
The threshold is not fixed. Federal law set it at $2,000 for 2025 and provides that each later year takes the previous figure and increases it by the annual growth in average spending on covered drugs, rounded to the nearest $50. That is how 2026 arrived at $2,100, and it is why the figure will keep moving.
What actually counts toward the ceiling
The statute counts incurred costs, and that is a defined term rather than a synonym for what came out of your own pocket. It is broader than people expect in one direction and narrower in another.
- Amounts borne by someone else still count where that someone is the low-income drug subsidy, a state pharmaceutical assistance program, the Indian Health Service or a tribal or urban Indian organization, or an AIDS drug assistance program.
- For 2025 and later, amounts reimbursed through other insurance or a group health plan generally count as well.
- What does not count is a manufacturer's payment under the discount program, and costs for a drug that is not on the plan's formulary.
Part 3
The option to spread it across the year
A ceiling on the annual amount does not help with the timing. Someone prescribed an expensive drug in January can meet a large share of the annual threshold in the first weeks of the year, which is a real bill arriving in a real month.
A separate program addresses exactly that. Instead of paying at the pharmacy counter, an enrollee can elect to have their out-of-pocket costs billed by the plan in monthly amounts spread across the remainder of the calendar year.
Three things about it are worth being clear on:
- It does not reduce what is owed. It changes when it is paid, and nothing else.
- It has to be elected. Nobody is enrolled automatically, and the value of it is highest for someone whose costs land early in a year.
- The amounts are billed by the plan rather than taken at the counter, so it creates a monthly bill that has to be paid like any other. Missing one ends the arrangement rather than the debt: the enrollee goes back to paying at the counter and still owes what was already billed.
Part 4
The penalty, and why it never ends
Federal regulation sets the late enrollment penalty as the greater of an actuarially determined amount or 1 percent of the base beneficiary premium for each uncovered month.
The base beneficiary premium is a national figure, not the premium of any particular plan, and it is recalculated every year. Three consequences follow, and each of them surprises people.
- It accumulates. Thirty uncovered months is 30 percent, not a flat charge. Sixty is 60 percent.
- It runs indefinitely. Under current law it attaches to the premium for as long as the person has Part D coverage, rather than for a set number of years. The one standing exception is in Part 7.
- It grows. Because it is a percentage of a national figure that rises over time, the dollar amount of the penalty rises every year without the percentage changing.
Changing plans does not shed it. Someone who moves to a different, cheaper plan carries the same percentage with them, because it is calculated from the national figure rather than from what their plan charges.
Part 5
What actually counts as an uncovered month
The trigger is precise. A penalty applies where, at any time after the end of a person's initial enrollment period, there is a continuous period of 63 days or longer during which all three of these were true:
- The person was eligible to enroll in a drug plan.
- The person was not covered by any creditable prescription drug coverage.
- The person was not enrolled in a drug plan.
The middle condition is the one that saves most people, and it is the one worth understanding. Creditable coverage means drug coverage expected to pay, on average, at least as much as standard Medicare drug coverage would. Coverage from a current or former employer, a union, or certain other sources often qualifies.
Often is not the same as obviously. Whether coverage is creditable is a determination the plan sponsor makes using an approved method and then has to disclose, at set points including before the annual enrollment period. Generous-looking coverage that has never been assessed and disclosed is not established as creditable simply because it seems adequate, which is why the notice matters more than the impression.
Someone covered that way for years owes nothing when they eventually join a plan, because none of those months was uncovered. The gap only starts running when the creditable coverage stops.
Part 6
The plan changes under you every year
A drug plan is not a fixed product. What it covers, at what tier, with what conditions attached, is revised annually and can move during a year as well. Two federal rules constrain that, and each of them is something to invoke rather than something that happens on its own.
The annual boundary
A plan may not change the therapeutic categories and classes in its formulary other than at the beginning of a plan year, except where the agency permits it for new uses and newly approved drugs. Wholesale restructuring is an annual event, which is precisely why the plan that suited you last year is a fresh question each autumn rather than a settled one.
The bridge when it does change
Federal rules require a plan to run a transition process for people prescribed drugs that are not on its formulary, including drugs that are on it but carry prior authorization or step therapy conditions. It has to cover new enrollees after the annual election period, people newly eligible from other coverage, people who switched plans mid-year, and, importantly, people who stayed in the same plan and were affected by a formulary change.
That last group is the one nobody expects to need it. Staying put is not the same as being unaffected.
It is also bounded. What the rules require is a temporary supply while the situation is sorted out, not an indefinite accommodation, and it does not extend to the immediate changes the agency permits a plan to make, such as a removal on safety grounds.
Part 7
The two ways out
A penalty determination is not the end of the matter, and there are two separate routes.
Reconsideration
Someone determined to be subject to a penalty may request reconsideration. The review is carried out by the agency or by an independent review entity it contracts with. Two features of it are unusual and worth knowing before relying on it: the decision is not itself subject to appeal, and the agency retains discretion to review and revise it.
The strongest ground is documentary. A penalty resting on months a person believes were covered is a question of evidence, which is why the letters in Part 5 matter.
The subsidy that removes it
The regulation that imposes the penalty carves out an exception for people receiving the low-income subsidy for drug costs. Someone who qualifies for that help is not charged the penalty while they have it.
That is a direct link to help that a great many people qualify for and never claim, and the two subjects are worth treating as one question rather than two.
The exception is written in the present tense and attaches to the status. Someone who has the subsidy is not subject to the penalty while they have it. It is not a one-time erasure of the record, so what happens if the subsidy is later lost is a question to put specifically rather than to assume.
Part 8
The one afternoon checklist
The first two are the ones that cost money permanently if skipped.
- If you are eligible for Medicare and have no drug coverage, find out whether the coverage you do have counts as creditable. Sixty three days without it starts the clock.
- Keep every annual notice from an employer, union or other plan saying whether its drug coverage is creditable. That letter is the evidence, and coverage that has never been assessed and disclosed is not established as creditable however good it looks.
- Check your plan's list of covered drugs against what you actually take, every year, before the year starts. Spending on a drug the plan does not cover does not count toward the ceiling.
- Note the two 2026 figures: the deductible and the out-of-pocket ceiling. Both change annually.
- If a drug you take comes off the formulary or gains a new condition, ask for the transition supply and start an exception request inside that window rather than after it.
- If a costly prescription is starting, ask about spreading the cost across the year before paying at the counter, rather than afterwards.
- If a penalty has been applied and you believe months were covered, request reconsideration and produce the letters.
- Check whether you qualify for help with drug costs. It removes the penalty while it applies, and it is the same question as help with premiums.
Part 9
Where these numbers come from
The out-of-pocket threshold was $2,000 for 2025, and each later year is the previous amount increased by the annual growth in average drug spending, rounded to the nearest $50
42 U.S.C. 1395w-102(b)(4)(B). Retrieved September 5, 2026.
The 2026 out-of-pocket threshold of $2,100 and the 2026 deductible of $615, and the phases: all of it to the deductible, 25 percent coinsurance, then no cost sharing
Centers for Medicare and Medicaid Services, Final CY 2026 Part D Redesign Program Instructions. Retrieved September 5, 2026.
The option to spread out-of-pocket costs across the year
Centers for Medicare and Medicaid Services, Medicare Prescription Payment Plan. Retrieved September 5, 2026.
A plan may not change formulary therapeutic categories and classes other than at the start of a plan year, and must run a transition process that covers people affected by a formulary change in a plan they stayed in
42 CFR 423.120(b). Retrieved September 5, 2026.
What counts as incurred costs toward the threshold, including amounts borne by named programs and, from 2025, amounts reimbursed by other insurance, but excluding manufacturer discount payments and non-formulary drugs
42 U.S.C. 1395w-102(b)(4)(C). Retrieved September 5, 2026.
Creditable coverage has to be determined by the sponsor and disclosed
42 CFR 423.56. Retrieved September 5, 2026.
Subsidy eligible individuals are not subject to the late enrollment penalty
42 CFR 423.780(e). Retrieved September 5, 2026.
The penalty is the greater of an actuarially sound amount or 1 percent of the base beneficiary premium for each uncovered month
42 CFR 423.286(d)(3). Retrieved September 5, 2026.
The 63 day trigger, the three conditions, and the requirement that plans collect prior coverage information
42 CFR 423.46(a) and (b). Retrieved September 5, 2026.
Reconsideration, and that the decision is not subject to appeal but may be revised
42 CFR 423.46(c). Retrieved September 5, 2026.
The exception for people receiving the low-income subsidy
42 CFR 423.46(a), referring to 42 CFR 423.780(e). Retrieved September 5, 2026.
This guide is educational information. It is not legal, tax or financial advice.
Update history
- September 5, 2026
- First published.
About Heavenly Finance
Heavenly Finance publishes guides on the money decisions that are easiest to get wrong: Medicare, Social Security, wills and estates, taxes in retirement, fraud and everyday money. Every figure traces to the agency page, statute or regulation it came from, with the date it was checked. How the guides are written and checked · Report an error